BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26301779)

  • 1. No evidence for αGal epitope transfer from media containing FCS onto human endothelial cells in culture.
    Ramm R; Hartmann T; Tudorache I; Haverich A; Hilfiker A
    Xenotransplantation; 2015; 22(5):345-55. PubMed ID: 26301779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells.
    Saethre M; Baumann BC; Fung M; Seebach JD; Mollnes TE
    Transplantation; 2007 Jul; 84(2):244-50. PubMed ID: 17667817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of CD59 up-regulation induced in porcine endothelial cells by alphaGal ligation and its association with protection from complement.
    Grubbs BC; Benson BA; Dalmasso AP
    Xenotransplantation; 2003 Sep; 10(5):387-97. PubMed ID: 12950982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decellularized GGTA1-KO pig heart valves do not bind preformed human xenoantibodies.
    Ramm R; Niemann H; Petersen B; Haverich A; Hilfiker A
    Basic Res Cardiol; 2016 Jul; 111(4):39. PubMed ID: 27154491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of carbohydrate xenoantigens on porcine peripheral nerve.
    Magnusson S; Strokan V; Svensson L; Månsson JE; Rydberg L; Breimer ME
    Xenotransplantation; 2005 Jan; 12(1):49-58. PubMed ID: 15598273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human NK cells can lyse porcine endothelial cells independent of their expression of Galalpha(1,3)-Gal and killing is enhanced by activation of either effector or target cells.
    Horvath-Arcidiacono JA; Porter CM; Bloom ET
    Xenotransplantation; 2006 Jul; 13(4):318-27. PubMed ID: 16768725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of target antigens for primate xenoreactive natural antibodies in pig and rat endothelial cells.
    Azimzadeh A; Wolf P; Thibaudeau K; Cinqualbre J; Soulillou JP; Anegon I
    Transplantation; 1997 Oct; 64(8):1166-74. PubMed ID: 9355835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of N-glycolylneuraminic acid xenoantigen on human adipose tissue-derived stromal cells/mesenchymal stem cells leads to safer and more useful cell sources for various stem cell therapies.
    Komoda H; Okura H; Lee CM; Sougawa N; Iwayama T; Hashikawa T; Saga A; Yamamoto-Kakuta A; Ichinose A; Murakami S; Sawa Y; Matsuyama A
    Tissue Eng Part A; 2010 Apr; 16(4):1143-55. PubMed ID: 19863253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of galactose-alpha-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity.
    Baumann BC; Forte P; Hawley RJ; Rieben R; Schneider MK; Seebach JD
    J Immunol; 2004 May; 172(10):6460-7. PubMed ID: 15128838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transplantation of corneal endothelial cells].
    Amano S
    Nippon Ganka Gakkai Zasshi; 2002 Dec; 106(12):805-35; discussion 836. PubMed ID: 12610838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
    Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
    Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo neutralization of naturally existing antibodies against linear alpha(1,3)-galactosidic carbohydrate epitopes by multivalent antigen presentation: a solution for the first hurdle of pig-to-human xenotransplantation.
    Duthaler RO; Ernst B; Fischer R; Katopodis AG; Kinzy W; Marterer W; Oehrlein R; Streiff MB; Thoma G
    Chimia (Aarau); 2010; 64(1-2):23-8. PubMed ID: 21137679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human natural antibodies cytotoxic to pig embryonic brain cells recognize novel non-Galalpha1,3Gal-based xenoantigens.
    Sumitran S; Liu J; Czech KA; Christensson B; Widner H; Holgersson J
    Exp Neurol; 1999 Oct; 159(2):347-61. PubMed ID: 10506507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation.
    Palmetshofer A; Galili U; Dalmasso AP; Robson SC; Bach FH
    Transplantation; 1998 Apr; 65(7):971-8. PubMed ID: 9565103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and quantification of porcine circulating endothelial cells.
    Post IC; Weenink RP; van Wijk AC; Heger M; Böing AN; van Hulst RA; van Gulik TM
    Xenotransplantation; 2013; 20(1):18-26. PubMed ID: 23347130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to anti-xenogeneic response by combining alpha-Gal silencing with HO-1 upregulation.
    Zhu M; Zhang W; Liu F; Wang L; Liu B; Chen D; Zhu XH; Zhang WJ; Ichim TE; Chen ZS; Zhou P; Chen S; Chen G
    Transpl Immunol; 2008 Jul; 19(3-4):202-8. PubMed ID: 18598766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gal alpha(1-3)Gal expression of the cornea in vitro, in vivo and in xenotransplantation.
    Lee HI; Kim MK; Oh JY; Ko JH; Lee HJ; Wee WR; Lee JH
    Xenotransplantation; 2007 Nov; 14(6):612-8. PubMed ID: 17991149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of anti-Gal alpha (1,3)Gal antibodies diminishes the cytotoxic effect of primate xenoreactive antibodies on rat endothelial cells.
    Azimzadeh A; Anegon I; Thibaudeau K; Charreau B; Zibolt P; Cinqualbre J; Soulillou JP; Wolf P
    Transplant Proc; 1997 Aug; 29(5):2337. PubMed ID: 9270751
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzymatic removal of alpha-galactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies.
    LaVecchio JA; Dunne AD; Edge AS
    Transplantation; 1995 Oct; 60(8):841-7. PubMed ID: 7482745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation.
    Baquerizo A; Mhoyan A; Kearns-Jonker M; Arnaout WS; Shackleton C; Busuttil RW; Demetriou AA; Cramer DV
    Transplantation; 1999 Jan; 67(1):5-18. PubMed ID: 9921790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.